Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of DWP14012 for erosive gastroesophageal reflux disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Gastroesophageal Reflux Disease

Drugs mentioned

• DWP14012

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Erosive Gastroesophageal Reflux Disease | Phase 2 | Status: COMPLETED